Af disse var blødning den mest almindelige bivirkning for begge lægemidler, som førte til seponering af forsøgsmedicinen (2, 5% for prasugrel og 1, 4% for clopidogrel).
Of these, bleeding was the most common adverse reaction for both drugs leading to study drug discontinuation (2.5% for prasugrel and 1.4% for clopidogrel).